←
Brittany Bromfield1,054 posts
Brittany Bromfield avatar

Brittany Bromfield

@brittybb

Jamaican 🩺 🇯🇲 in Boston📍 Liver @massgenbrigham @BrighamGI | MPH @harvardchanSPH

◷ Joined March 2020▧ 116 Photos and videos
Brittany Bromfield avatar
Brittany Bromfield@brittybb·Jun 4

Yesterday I graduated from @BrighamGI fellowship, and today I get to celebrate my first @NEJM publication. Feeling very grateful, very lucky, and very excited for what’s next. 🎓📄✨

Post attachmentPost attachmentPost attachmentPost attachment
KathleenCorey avatar
⟳ Brittany Bromfield retweeted
KathleenCorey@KathleenCoreyMD·Aug 2

Exciting time in MASLD, lots of emerging compounds. One to know => survodutide ➡️ GLPRA/Glucagon agonist ➡️ unlike GLP, liver has glucagon receptors so survodutide acts directly on the liver ➡️ SYNCHRONIZE-MASLD 2026 - MASLD pts defined by MRI (~90%) likely with F0-2 - survodutide met co-primary endpoints 1. 84% had =>30% reduction in liver fat

Brigham and Women's GI avatar
⟳ Brittany Bromfield retweeted
Brigham and Women's GI@BrighamGI·Jul 17

Congratulations to our incredible Program Director, Dr. Molly Perencevich, on receiving the @MassGenBrigham Graduate Medical Education Outstanding Program Director Award, selected from among all training programs throughout the MGB system🏆 Thank you, Molly, for your unwavering dedication to fellow education, mentorship, and exceptional leadership. So well deserved! 👏🎉

Post attachment
Northwestern Medicine Transplant avatar
⟳ Brittany Bromfield retweeted
Northwestern Medicine Transplant@NM_Transplant·May 29

Andres Duarte-Rojo, MD, is a part of a team leading Northwestern Medicine's efforts to enhance survival of patients who are preparing for liver transplantation through a personalized at-home program that assesses mobility, exercise, diet and more. This program prepares patients for transplantation and aims to reduce post-transplant complications and hospital admissions. Read the full article: breakthroughsforphysicians.n…

Post attachment
The Lancet avatar
⟳ Brittany Bromfield retweeted
The Lancet@TheLancet·Apr 30

Alcohol use disorder accounts for 5% of deaths worldwide annually, and there is an urgent need for new treatments. A new study found that GLP-1 reduces heavy drinking days in treatment seeking people with alcohol use disorder and obesity: spkl.io/6012AfU04

Post attachment
Brittany Bromfield avatar
Brittany Bromfield@brittybb·Apr 10

The kind of studies I LOVE to see

Too many people are put on lifelong levothyroxine for borderline TSH elevations or nonspecific symptoms, then never reassessed, yet trials show little benefit for most with subclinical hypothyroidism and risks from overtreatment like a-fib and bone loss. We need to normalize “deprescribing” thyroid hormone when it was started for borderline labs, low doses, or no clear diagnosis, and routinely see if patients can come off instead of renewing forever. jamanetwork.com/journals/jam…

Post attachment
Brittany Bromfield avatar
Brittany Bromfield@brittybb·Apr 10

The best of the best !

Andres Duarte-Rojo (@YucaSpice), MD, professor of Medicine and Surgery at Northwestern Medicine, and Susanna Miranda, DNP, APRN, lead a multidisciplinary liver transplant rehabilitation team that aims to reduce frailty and enhance survival for patients preparing for liver transplantation. See how this program is improving post-transplant outcomes: breakthroughsforphysicians.n…

Post attachment
Hanna Blaney, MD, MPH avatar
⟳ Brittany Bromfield retweeted
Hanna Blaney, MD, MPH@BlaneyMD·Mar 2

📢Check out our new study in @HEP_Journal showing that AUD pharmacotherapy is associated with: 📉 Hospitalizations & costs ‼️Especially cost-saving in those with liver disease AUD pharmacotherapy improves both patient & healthcare system outcomes (🏥💰) journals.lww.com/hep/abstrac…

Post attachment